RxDoctor Payments Data

Sean Kark, DO

Family Medicine · Highlands Ranch, CONPI 1588025589

Payments from drug & device makers

$3,676in general payments, 2019–2025

Across 116 payments — averaging $31.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$823
  • AbbVie$479
  • Pfizer$393
  • Novo Nordisk$251
  • GSK$249
  • Johnson & Johnson$203
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$3,676100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,676 in reported general payments places this provider in the 90th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$56,820
Medicare patients
206
Services billed
872

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban54$53,625
JardianceEmpagliflozin31$30,508
Nurtec OdtRimegepant Sulfate13$22,213
TrulicityDulaglutide17$21,425
XareltoRivaroxaban21$20,348
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$8,551
Potassium Chloride50$6,203
SymbicortBudesonide/Formoterol Fumarate12$4,881
Levothyroxine Sodium239$2,799
Atorvastatin Calcium272$2,690
Albuterol Sulfate HfaAlbuterol Sulfate77$2,209
SynthroidLevothyroxine Sodium18$1,701
ValacyclovirValacyclovir Hcl25$1,546
Losartan Potassium143$1,445
Rosuvastatin Calcium147$1,395

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt$393$75,83867 claims
Boehringer IngelheimJardiance$93$30,50831 claims
Lilly USA, LLCTrulicity$127$21,42517 claims
Johnson & JohnsonXarelto$203$20,34821 claims
AstraZenecaBreztri Aerosphere, Symbicort$823$13,43224 claims
AbbVieSynthroid$479$1,70118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Highlands Ranch

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →